MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Hemangioma

(UMLS:C0018916)

Definition:: A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
UMLS ID:: C0018916
MeSH ID:: D006391

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.645.375

Synonym(s)

Hemangioma

Angioma

Angioma, NOS

Benign Angioma

Benign Hemangioma

Benign haemangioma

Benign hemangioma

HEMANGIOMA

HEMANGIOMA, BENIGN

10.

Haemangioma

11.

Haemangioma - morphology

12.

Haemangioma NOS

13.

Haemangioma of unspecified site

14.

Haemangioma, NOS

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Alcohols	27840117	CTD
2	Azathioprine	1420764	CTD
3	Betamethasone	15107744	CTD
4	Diethylnitrosamine	3702427	CTD
5	Imiquimod	16302556	CTD
6	Lithium	12692718	CTD
7	Methylprednisolone Acetate	12055481	CTD
8	Nandrolone Decanoate	3702427	CTD
9	Phenelzine	943238	CTD
10	Prednisolone	11773735	CTD
11	Prednisone	11937956	CTD
12	Propranolol	19743301 21493392 30130526	CTD
13	Valproic Acid	1729766	CTD
14	alpha-hydroxyglutarate	22057236	CTD
15	tesaglitazar	22131108	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Angiokeratoma	46.7%
2	hemangiopericytoma	46.7%
3	Angiofibroma	46.7%
4	Hemangiosarcoma	40.7%
5	leukemia	31%
6	Neoplasms, Germ Cell and Embryonal	31%
7	Neoplasms, Glandular and Epithelial	31%
8	Germ Cell Cancer	31%
9	Meningioma	27.9%
10	Neuroectodermal Tumors	26.7%
11	Neoplasms, Neuroepithelial	24.6%
12	Gliomatosis cerebri	24.6%
13	Carcinosarcoma	23.1%
14	lymphangiosarcoma	23.1%
15	melanoma	22%
16	Histiocytic Disorders, Malignant	20.5%
17	Adenoma	20%
18	Ameloblastoma	20%
19	Carcinoma	20%
20	Chordoma	20%
21	Lymphangioma	20%
22	Mesenchymoma	20%
23	Nevus	20%
24	Teratoma	20%
25	Hepatoblastoma	20%
26	Mixed Tumor, Mullerian	20%
27	Germinoma	20%
28	Teratocarcinoma	20%
29	Sarcoma	20%
30	Epithelioma	20%
31	Basal cell carcinoma	19.6%
32	Carcinoma, Papillary	19.6%
33	Squamous cell carcinoma	19.6%
34	Chondrosarcoma	19.6%
35	Craniopharyngioma	19.6%
36	Cystadenoma	19.6%
37	leiomyosarcoma	19.6%
38	liposarcoma	19.6%
39	Mesothelioma	19.6%
40	synovial sarcoma	19.6%
41	Neuroectodermal Tumor, Melanotic	19.6%
42	Angiomyolipoma	19.6%
43	Clear Cell Sarcoma of Soft Tissue	19.6%
44	Alveolar Soft Part Sarcoma	19.6%
45	Neuroendocrine Tumors	19.6%
46	Sarcoma, Myeloid	19.6%
47	Carcinoma, Basal Cell	19.6%
48	Adenoma, Acidophil	19.4%
49	Ganglioneuroma	19.4%
50	Glioma	19.4%
51	Malignant Glioma	19.4%
52	Medulloblastoma	19.1%
53	Carcinoma 256, Walker	18.7%
54	Hamartoma	18.5%
55	Neoplasms, Hormone-Dependent	18.5%
56	Neoplasms, Multiple Primary	18.5%
57	Paraneoplastic Syndromes	18.5%
58	Precancerous Conditions	18.5%
59	Neoplasms, Second Primary	18.5%
60	Carcinoid Tumor	18.1%
61	Neurilemmoma	18.1%
62	Hutchinson's Melanotic Freckle	18.1%
63	Melanoma, Amelanotic	18.1%
64	Cystadenocarcinoma	17.8%
65	Fibrosarcoma	17.8%
66	Osteosarcoma	17.8%
67	Mucoepidermoid Carcinoma	17.8%
68	Leukemia, Plasma Cell	17.2%
69	Adenofibroma	17%
70	Fibroadenoma	17%
71	Malignant Fibrous Histiocytoma	17%
72	Carcinoma, Ehrlich Tumor	16.9%
73	Dermoid Cyst	16.9%
74	Carcinoma, Lewis Lung	16.9%
75	Astrocytoma	16.8%
76	Ependymoma	16.8%
77	oligodendroglioma	16.8%
78	Ganglioglioma	16.8%
79	gliosarcoma	16.8%
80	Anaplastic astrocytoma	16.8%
81	Anaplastic Oligodendroglioma	16.8%
82	Malignant Carcinoid Syndrome	16.2%
83	Bowen's Disease	16.1%
84	Paraganglioma	16.1%
85	Rhabdomyosarcoma	16.1%
86	Giant Cell Tumor of Bone	16.1%
87	Composite Lymphoma	15.8%
88	Glioblastoma	15.5%
89	Neuroblastoma	15.5%
90	Glioblastoma Multiforme	15.5%
91	Melanoma, Experimental	15.5%
92	Dermatofibrosarcoma	15.3%
93	Dermatofibrosarcoma Protuberans	15.3%
94	Lymphoma	15.3%
95	Trophoblastic Neoplasms	15.3%
96	Leukemia, Experimental	15.1%
97	Ganglioneuroblastoma	14.9%
98	Adenocarcinoma	14.8%
99	Carcinoma in Situ	14.8%
100	Carcinoma, Transitional Cell	14.8%
101	Phyllodes Tumor	14.8%
102	Dysgerminoma	14.8%
103	Lipoma	14.8%
104	Myoma	14.8%
105	Myxoma	14.8%
106	Neuroma	14.8%
107	Papilloma	14.8%
108	Pseudomyxoma Peritonei	14.8%
109	Seminoma	14.8%
110	Papillomatosis	14.8%
111	Angiolipoma	14.8%
112	Myelolipoma	14.8%
113	Neoplasms, Bone Tissue	14.8%
114	Neoplasms, Fibrous Tissue	14.8%
115	Smooth Muscle Tumor	14.8%
116	Adenomatosis, Pulmonary	14.8%
117	Adenomatous Polyps	14.8%
118	Carcinoma, Large Cell	14.8%
119	Carcinoma, Small Cell	14.8%
120	Desmoplastic Small Round Cell Tumor	14.8%
121	Chondroma	14.8%
122	Enchondroma	14.8%
123	Pheochromocytoma	14.4%
124	Alveolar rhabdomyosarcoma	14.4%
125	Leukemia L1210	14.3%
126	Leukemia P388	14.3%
127	Acanthoma	14.3%
128	Choriocarcinoma	13.4%
129	Carcinoma, Lobular	13.4%
130	Plasmacytoma	13.3%
131	Malignant histiocytosis	13.2%
132	Histiocytic sarcoma	13.2%
133	Sarcoma 180	12.6%
134	Endometrial Stromal Sarcoma	12.6%
135	Sarcoma, Experimental	12.5%
136	Carcinoid Heart Disease	12.4%
137	Thymoma	12.4%
138	Leukemia, Radiation-Induced	12.2%
139	Adenoid Cystic Carcinoma	12.2%
140	Cyst	12.2%
141	fibroma	12.2%
142	Fibromatosis	12.2%
143	Neoplastic Processes	12.2%
144	Neoplastic Syndromes, Hereditary	12.2%
145	Osteoblastoma	12.2%
146	Osteoma	12.2%
147	Pregnancy Complications, Neoplastic	12.2%
148	Rhabdomyoma	12.2%
149	Chondromatosis	12.2%
150	Adenocarcinoma, Clear Cell	12.2%
151	Cholangiocarcinoma	12.2%
152	Cervical Intraepithelial Neoplasia	12.2%
153	Lymphoma, Extranodal NK-T-Cell	12.2%
154	Neoplasms, Experimental	11.9%
155	Lymphangioleiomyomatosis	11.7%
156	Neurofibrosarcoma	11.6%
157	Retinoblastoma	11.1%
158	Fibromatosis, Aggressive	10.9%
159	Fibromatosis, Abdominal	10.9%
160	Klatskin Tumor	10.9%
161	Abdominal Neoplasms	10.3%
162	Erythroplasia	10.3%
163	Follicular cyst	10.3%
164	Head and Neck Neoplasms	10.3%
165	Mucocele	10.3%
166	Pilonidal Cyst	10.3%
167	Soft Tissue Neoplasms	10.3%
168	Thoracic Neoplasms	10.3%
169	Thyroglossal Cyst	10.3%
170	Synovial Cyst	10.3%
171	Aberrant Crypt Foci	10.3%
172	Hodgkin Disease	9.8%
173	Lymphoma, Non-Hodgkin	9.8%
174	Leukemia, Myelomonocytic, Chronic	9.8%
175	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.8%
176	Multiple Endocrine Neoplasia	9.2%
177	Neoplasms, Radiation-Induced	8.8%
178	Lymphomatoid Granulomatosis	8.8%
179	Paraneoplastic Encephalomyelitis	8.6%
180	Hydatidiform Mole	8.5%
181	Mammary Neoplasms, Experimental	8.4%
182	Acoustic Neuroma	8.4%
183	Carcinoma, Pancreatic Ductal	8.3%
184	Mastocytoma	8.2%
185	Mastocytosis, Systemic	8.1%
186	Leukemia, Myeloid, Chronic-Phase	8.1%
187	Primary amyloidosis	7.9%
188	Hepatocellular Adenoma	7.9%
189	Basal Cell Nevus Syndrome	7.7%
190	Mastocytosis	7.6%
191	Optic Nerve Glioma	7.5%
192	Nephroblastoma	7.5%
193	Gastrointestinal Stromal Tumors	7.4%
194	Vipoma	7.4%
195	Digestive System Neoplasms	7.3%
196	Endocrine Gland Neoplasms	7.3%
197	Eye Neoplasms	7.3%
198	Leukemia, T-Cell	7.3%
199	Nervous System Neoplasms	7.3%
200	Leukemia, B-Cell	7.3%
201	neurofibroma	7.3%
202	Lymphoma, Follicular	7.3%
203	T-Cell Lymphoma	7.3%
204	Mantle cell lymphoma	7.3%
205	Bone neoplasms	7%
206	Leukoplakia	7%
207	Lymphocele	7%
208	Pancreatic Cyst	7%
209	Skin Neoplasms	7%
210	Hematologic Neoplasms	7%
211	Barrett Esophagus	6.8%
212	Breast Cyst	6.8%
213	Actinic keratosis	6.8%
214	Mediastinal Cyst	6.8%
215	Neoplasm Invasiveness	6.8%
216	Neoplasm Metastasis	6.8%
217	Neoplasm Recurrence, Local	6.8%
218	Parovarian Cyst	6.8%
219	Pericardial Cyst	6.8%
220	Splenic Neoplasms	6.8%
221	Thymic Cyst	6.8%
222	Carcinogenesis	6.8%
223	Myxoid cyst	6.8%
224	Metastasis	6.8%
225	Mesoblastic Nephroma	6.7%
226	Retroperitoneal Neoplasms	6.7%
227	Prolactinoma	6.5%
228	Growth Hormone-Secreting Pituitary Adenoma	6.5%
229	Tuberous Sclerosis	6.1%
230	Multiple Endocrine Neoplasia Type 1	6%
231	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	6%
232	Leukemia, Large Granular Lymphocytic	6%
233	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	6%
234	Lymphoma, T-Cell, Cutaneous	6%
235	Lymphoma, AIDS-Related	6%
236	Enteropathy-Associated T-Cell Lymphoma	6%
237	Primary Effusion Lymphoma	6%
238	insulinoma	5.7%
239	Waldenstrom Macroglobulinemia	5.7%
240	Multiple Myeloma	5.7%
241	Dupuytren Contracture	5.6%
242	granulosa cell tumor	5.5%
243	Carcinoma, Ovarian Epithelial	5.5%
244	Urticaria Pigmentosa	5.5%
245	Parathyroid Neoplasms	5.5%
246	Peritoneal Neoplasms	5.5%
247	Thyroid Neoplasm	5.5%
248	Thyroid carcinoma	5.5%
249	Gastrinoma	5.4%
250	Glucagonoma	5.4%
251	Mycosis Fungoides	5.4%
252	Lymphomatoid Papulosis	5.4%
253	Plasmablastic lymphoma	5.4%
254	Adrenocortical carcinoma	5.4%
255	Adenomatous Polyposis Coli	5.1%
256	Corpus Luteum Cyst	5%
257	Ovarian Cysts	5%
258	Liver Neoplasms, Experimental	5%
259	Leydig Cell Tumor	4.9%
260	Tracheal Neoplasms	4.8%
261	Leukoplakia, Oral	4.6%
262	Paraneoplastic Cerebellar Degeneration	4.6%
263	Pancreatic Neoplasm	4.6%
264	Renal Cell Carcinoma	4.6%
265	Papillary Renal Cell Carcinoma	4.6%
266	Mouth Neoplasms	4.5%
267	Central Nervous System Neoplasms	4.5%
268	Vascular Neoplasms	4.5%
269	Thymus Neoplasms	4.5%
270	Nasopharyngeal carcinoma	4.5%
271	Carcinoma, Endometrioid	4.4%
272	Genital Neoplasms, Female	4.4%
273	Pancreatic Pseudocyst	4.4%
274	Lymphatic Metastasis	4.4%
275	Neoplasms, Unknown Primary	4.4%
276	Leukemic Infiltration	4.4%
277	Breast Neoplasms, Male	4.4%
278	Neoplasm Micrometastasis	4.4%
279	Triple Negative Breast Neoplasms	4.4%
280	Choledochal Cyst	4.1%
281	Burkitt Lymphoma	4%
282	Peutz-Jeghers Syndrome	4%
283	Thyroid Nodule	3.9%
284	Esophageal Neoplasms	3.9%
285	Limbic Encephalitis	3.8%
286	Denys-Drash Syndrome	3.8%
287	Sezary Syndrome	3.6%
288	Adrenal Gland Neoplasms	3.4%
289	Gastrointestinal Neoplasms	3.4%
290	Genital Neoplasms, Male	3.4%
291	Liver neoplasms	3.4%
292	Uveal Neoplasms	3.4%
293	Urologic Neoplasms	3.4%
294	Lambert-Eaton Myasthenic Syndrome	3.3%
295	Testicular Neoplasms	3.3%
296	Sebaceous Gland Neoplasms	3.3%
297	Spinal Neoplasms	3.3%
298	Bone Marrow Neoplasms	3.3%
299	Meningeal Neoplasms	3.3%
300	Polycystic Ovary Syndrome	3.3%
301	Opsoclonus-Myoclonus Syndrome	2.9%
302	Meningeal Carcinomatosis	2.7%
303	Palatal Neoplasms	2.6%
304	Ear Neoplasms	2.6%
305	Eyelid Neoplasms	2.6%
306	Lung Neoplasms	2.6%
307	Pleural Neoplasms	2.6%
308	Myelitis, Transverse	2.6%
309	Nose Neoplasms	2.6%
310	Cell Transformation, Viral	2.5%
311	Brain Neoplasms	2.5%
312	Salivary Gland Neoplasms	2.5%
313	Spinal Cord Neoplasms	2.5%
314	Tongue Neoplasms	2.5%
315	Uterine Neoplasms	2.4%
316	Vaginal Neoplasms	2.4%
317	Vulvar Neoplasms	2.4%
318	Uterine Cancer	2.4%
319	Fallopian Tube Neoplasms	2.4%
320	Xeroderma Pigmentosum	2.2%
321	Pituitary Adenoma	2.2%
322	Pituitary Neoplasms	2.2%
323	ovarian neoplasm	2.2%
324	Bronchial Neoplasms	2.1%
325	Pharyngeal Neoplasms	2.1%
326	Multiple Pulmonary Nodules	2.1%
327	Supratentorial Neoplasms	2%
328	Central Nervous System Cysts	2%
329	Endometrial Neoplasms	2%
330	Bile Duct Neoplasms	2%
331	gallbladder neoplasm	2%
332	Intestinal Neoplasms	2%
333	Penile Neoplasms	2%
334	Prostatic Neoplasms	2%
335	Stomach Neoplasms	2%
336	Polycythemia Vera	1.9%
337	Brain Stem Neoplasms	1.8%
338	Laryngeal neoplasm	1.7%
339	Choroid Plexus Papilloma	1.7%
340	Hypopharyngeal Neoplasms	1.7%
341	Pleural Effusion, Malignant	1.7%
342	Hypopharyngeal Cancer	1.7%
343	Zollinger-Ellison syndrome	1.6%
344	Bladder Neoplasm	1.6%
345	Kidney Neoplasm	1.6%
346	Ureteral Neoplasms	1.6%
347	Urethral Neoplasms	1.6%
348	Parotid Neoplasms	1.6%
349	Prostatic Neoplasms, Castration-Resistant	1.6%
350	Nelson Syndrome	1.6%
351	Tonsillar Neoplasms	1.5%
352	Cerebellar Neoplasms	1.4%
353	Cecal Neoplasms	1.3%
354	Duodenal Neoplasms	1.3%
355	Radicular Cyst	1.2%
356	Appendiceal Neoplasms	1.2%
357	Colonic Neoplasms	1.2%
358	Rectal Neoplasms	1.2%
359	Nasopharyngeal Neoplasms	1.2%
360	Colorectal Neoplasms	1.2%
361	Paranasal Sinus Neoplasms	1%
362	Anus Neoplasms	1%
363	Sigmoid Neoplasms	1%
364	Maxillary Sinus Neoplasms	0.9%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234